Friday, September 11, 2009

AstraZeneca reported to cut 113 jobs

By Mass High Tech staff

Video Gallery

The Departed: MHT tracks Greater Boston companies leaving, shutting down

MHT's Julie Donnelly: Life science startups finding investments

MHT's Galen Moore: Hiring trends and opportunities

Related News

Alkermes to push opioid dependence treatment for FDA approval [November 16, 2009]

Putney pulls in $6.7M, plans growth [November 16, 2009]

Biotech, pharma foresee higher costs from House health reform bill [November 13, 2009]

Altus files for Ch. 7 bankruptcy [November 12, 2009]

Ironwood to net $75M from licensing deal in Japan [November 10, 2009]

London pharmaceutical giant AstraZeneca PLC, which runs some local operations in Massachusetts, is losing 113 jobs from its manufacturing plant in Westborough, as of early October, according to the Boston Globe.

The report indicates that growing competition in the company’s asthma medication market factored in to the job cuts.

AstraZeneca also operates a research and development facility in Waltham, where the company will soon celebrate the opening of its newly expanded office, the Globe reports. In January of 2007, AstraZeneca announced a $100 million investment to add 132,000 square feet to its facilities. At the time, the investment was intended to boost work in the infectious disease area and continue its growth in cancer research. Ironically, the expanded office could house up to 100 additional researchers, according to an earlier report.